United States Eleventh Circuit

Analogue Act, 21 U.S.C. section 813, as applied to gamma-butyrolactone (GBL), is not unconstitutionally vague, and sellers of bodybuilding products had constitutional notice that GBL was a controlled substance analogue of gamma-hydroxybutyrate acid (GHB).

Appellate Information

• Decided 05/02/2002
• Published 05/02/2002

Judges

• RICHARD MILLS, District Judge:, Before ANDERSON, Chief Judge, DUBINA, Circuit Judge, and MILLS , District Judge.

Court

• United States Eleventh Circuit

Counsel

• For Appellant:
  
• Carlos A. Williams (Court-Appointed), Fed. Pub. Def., Mobile, AL, for Sutton., Charles A. Kandt, Patsy Busby Dow, Mobile, AL, for U.S.


• For Appellees:
  
• Joseph L. Hammons,Hammons & Whitaker, P.A., Pensacola, FL, Kristen Gartman Rogers, Fed. Pub. Def., W.A. Kimbrough, Jr., Turner, Onderdonk, Kimbrough & Howell, P.A., Mobile, AL, for Defendants-Appellants.